نتائج البحث 651-660 من 23102 لعملية البحث عن Treatment
... Treatment Or Is Difficult To Treat - A Leukemia & Lymphoma Society And ... treatment) in Breast Cancer 1/2 genes (BRCA 1/2) and PALB2 associated HER2 ...
... treatment of progressive post-hemorrhagic hydrocephalus in neonates with the focus on comparing neuroendoscopic lavage (NEL) with other standard treatment ...
... treatment (refractory). A Study To Evaluate Azacitidine Plus Venetoclax Induction Chemotherapy To Treat Acute Myeloid Leukemia Patients For T-cell Directed ...
... treatment. Leveraging Methylated DNA Markers (MDMs) In The Detection Of Endometrial Cancer And Cervical Cancer: A Phase II Clinical Study. La Crosse, Wis ...
... treatment. A Registry to Follow Long-Term Outcomes for Mother and Child Pairs After Fetal Surgery for Spina Bifida. Rochester, Minn. The purpose of this ...
... treatment, in order to classify patients into post-consolidation treatment groups. ... treatment in patients with recurrent grade 2 or 3 meningioma as ...
... treatment. CraniSeal Post Approval Study. Rochester, Minn., Jacksonville, Fla. To collect post-approval data comparing the safety and effectiveness of ...
... treatment of patients with chronic myelomonocytic leukemia that has come back (recurrent) or that does not respond to treatment (refractory). Onvansertib is ...
Once this is complete treatment will be directed based on the genomic signature of patients individual tumor. ... The purpose of this study is to compare ...
Pituitary tumor registry. Rochester, Minn. The purpose of this data registry involves the collection of standard of care clinical treatment regimens, diagnostic ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.